 | • レポートコード：D005-00645 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、黒色腫治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。黒色腫治療の種類別市場規模（化学療法、免疫療法、標的療法、放射線療法）、用途別市場規模（オプジーボ、ヤーボイ、メカニスト + タフィンラー、キイトルーダ、コテル、ゼルボラフ、Imlygic、ジェネリック）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：AstraZeneca、AB Sciences、Bristol-Myers Squibb Company、Amgen, Inc.、Daiichi Sankyo Company, Limited、F. Hoffmann-La Roche Ltd.、Merck & Co., Inc.、Novartis AG ・地域別グローバル市場分析 2015年-2020年 ・黒色腫治療の北米市場（アメリカ、カナダ、メキシコ） ・黒色腫治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・黒色腫治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・黒色腫治療の南米市場（ブラジル、アルゼンチン） ・黒色腫治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：化学療法、免疫療法、標的療法、放射線療法 ・用途別分析：オプジーボ、ヤーボイ、メカニスト + タフィンラー、キイトルーダ、コテル、ゼルボラフ、Imlygic、ジェネリック ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Melanoma Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Melanoma Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Melanoma Therapeutics market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Melanoma Therapeutics market has been segmented into:
Chemotherapy
Immunotherapy
Targeted Therapy
Radiation Therapy
By Application, Melanoma Therapeutics has been segmented into:
Opdivo
Yervoy
Mekinist+Tafinlar
Keytruda
Cotellic
Zelboraf
Imlygic
Generics
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Melanoma Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level Melanoma Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Melanoma Therapeutics market.
The report offers in-depth assessment of the growth and other aspects of the Melanoma Therapeutics market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Melanoma Therapeutics Market Share Analysis
Melanoma Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Melanoma Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Melanoma Therapeutics sales, revenue and market share for each player covered in this report.
The major players covered in Melanoma Therapeutics are:
AstraZeneca
AB Sciences
Bristol-Myers Squibb Company
Amgen, Inc.
Daiichi Sankyo Company, Limited
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Novartis AG
Table of Contents
1 Melanoma Therapeutics Market Overview
1.1 Product Overview and Scope of Melanoma Therapeutics
1.2 Classification of Melanoma Therapeutics by Type
1.2.1 Global Melanoma Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Melanoma Therapeutics Revenue Market Share by Type in 2019
1.2.3 Chemotherapy
1.2.4 Immunotherapy
1.2.5 Targeted Therapy
1.2.6 Radiation Therapy
1.3 Global Melanoma Therapeutics Market by Application
1.3.1 Overview: Global Melanoma Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Opdivo
1.3.3 Yervoy
1.3.4 Mekinist+Tafinlar
1.3.5 Keytruda
1.3.6 Cotellic
1.3.7 Zelboraf
1.3.8 Imlygic
1.3.9 Generics
1.4 Global Melanoma Therapeutics Market by Regions
1.4.1 Global Melanoma Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Melanoma Therapeutics (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Melanoma Therapeutics Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Melanoma Therapeutics Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Melanoma Therapeutics Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Melanoma Therapeutics Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Melanoma Therapeutics Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.2 AB Sciences
2.2.1 AB Sciences Details
2.2.2 AB Sciences Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 AB Sciences SWOT Analysis
2.2.4 AB Sciences Product and Services
2.2.5 AB Sciences Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol-Myers Squibb Company
2.3.1 Bristol-Myers Squibb Company Details
2.3.2 Bristol-Myers Squibb Company Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol-Myers Squibb Company SWOT Analysis
2.3.4 Bristol-Myers Squibb Company Product and Services
2.3.5 Bristol-Myers Squibb Company Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.4 Amgen, Inc.
2.4.1 Amgen, Inc. Details
2.4.2 Amgen, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Amgen, Inc. SWOT Analysis
2.4.4 Amgen, Inc. Product and Services
2.4.5 Amgen, Inc. Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.5 Daiichi Sankyo Company, Limited
2.5.1 Daiichi Sankyo Company, Limited Details
2.5.2 Daiichi Sankyo Company, Limited Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Daiichi Sankyo Company, Limited SWOT Analysis
2.5.4 Daiichi Sankyo Company, Limited Product and Services
2.5.5 Daiichi Sankyo Company, Limited Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.6 F. Hoffmann-La Roche Ltd.
2.6.1 F. Hoffmann-La Roche Ltd. Details
2.6.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.6.4 F. Hoffmann-La Roche Ltd. Product and Services
2.6.5 F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.7 Merck & Co., Inc.
2.7.1 Merck & Co., Inc. Details
2.7.2 Merck & Co., Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Merck & Co., Inc. SWOT Analysis
2.7.4 Merck & Co., Inc. Product and Services
2.7.5 Merck & Co., Inc. Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
2.8 Novartis AG
2.8.1 Novartis AG Details
2.8.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Novartis AG SWOT Analysis
2.8.4 Novartis AG Product and Services
2.8.5 Novartis AG Melanoma Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Melanoma Therapeutics Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Melanoma Therapeutics Players Market Share
3.2.2 Top 10 Melanoma Therapeutics Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Melanoma Therapeutics Revenue and Market Share by Regions
4.2 North America Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
4.3 Europe Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
4.5 South America Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
5 North America Melanoma Therapeutics Revenue by Countries
5.1 North America Melanoma Therapeutics Revenue by Countries (2015-2020)
5.2 USA Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
5.3 Canada Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
5.4 Mexico Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
6 Europe Melanoma Therapeutics Revenue by Countries
6.1 Europe Melanoma Therapeutics Revenue by Countries (2015-2020)
6.2 Germany Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
6.3 UK Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
6.4 France Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
6.5 Russia Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
6.6 Italy Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Melanoma Therapeutics Revenue by Countries
7.1 Asia-Pacific Melanoma Therapeutics Revenue by Countries (2015-2020)
7.2 China Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
7.3 Japan Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
7.4 Korea Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
7.5 India Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
8 South America Melanoma Therapeutics Revenue by Countries
8.1 South America Melanoma Therapeutics Revenue by Countries (2015-2020)
8.2 Brazil Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
8.3 Argentina Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Melanoma Therapeutics by Countries
9.1 Middle East & Africa Melanoma Therapeutics Revenue by Countries (2015-2020)
9.2 Saudi Arabia Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
9.3 UAE Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
9.4 Egypt Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
9.5 South Africa Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Melanoma Therapeutics Revenue and Market Share by Type (2015-2020)
10.2 Global Melanoma Therapeutics Market Forecast by Type (2019-2024)
10.3 Chemotherapy Revenue Growth Rate (2015-2025)
10.4 Immunotherapy Revenue Growth Rate (2015-2025)
10.5 Targeted Therapy Revenue Growth Rate (2015-2025)
10.6 Radiation Therapy Revenue Growth Rate (2015-2025)
11 Global Melanoma Therapeutics Market Segment by Application
11.1 Global Melanoma Therapeutics Revenue Market Share by Application (2015-2020)
11.2 Melanoma Therapeutics Market Forecast by Application (2019-2024)
11.3 Opdivo Revenue Growth (2015-2020)
11.4 Yervoy Revenue Growth (2015-2020)
11.5 Mekinist+Tafinlar Revenue Growth (2015-2020)
11.6 Keytruda Revenue Growth (2015-2020)
11.7 Cotellic Revenue Growth (2015-2020)
11.8 Zelboraf Revenue Growth (2015-2020)
11.9 Imlygic Revenue Growth (2015-2020)
11.10 Generics Revenue Growth (2015-2020)
12 Global Melanoma Therapeutics Market Size Forecast (2021-2025)
12.1 Global Melanoma Therapeutics Market Size Forecast (2021-2025)
12.2 Global Melanoma Therapeutics Market Forecast by Regions (2021-2025)
12.3 North America Melanoma Therapeutics Revenue Market Forecast (2021-2025)
12.4 Europe Melanoma Therapeutics Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Melanoma Therapeutics Revenue Market Forecast (2021-2025)
12.6 South America Melanoma Therapeutics Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Melanoma Therapeutics Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Melanoma Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Melanoma Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Melanoma Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Melanoma Therapeutics Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Melanoma Therapeutics Major Business
Table 7. AstraZeneca Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Melanoma Therapeutics Product and Solutions
Table 10. AstraZeneca Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. AB Sciences Corporate Information, Location and Competitors
Table 12. AB Sciences Melanoma Therapeutics Major Business
Table 13. AB Sciences Melanoma Therapeutics Total Revenue (USD Million) (2018-2019)
Table 14. AB Sciences SWOT Analysis
Table 15. AB Sciences Melanoma Therapeutics Product and Solutions
Table 16. AB Sciences Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bristol-Myers Squibb Company Corporate Information, Location and Competitors
Table 18. Bristol-Myers Squibb Company Melanoma Therapeutics Major Business
Table 19. Bristol-Myers Squibb Company Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 20. Bristol-Myers Squibb Company SWOT Analysis
Table 21. Bristol-Myers Squibb Company Melanoma Therapeutics Product and Solutions
Table 22. Bristol-Myers Squibb Company Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Amgen, Inc. Corporate Information, Location and Competitors
Table 24. Amgen, Inc. Melanoma Therapeutics Major Business
Table 25. Amgen, Inc. Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 26. Amgen, Inc. SWOT Analysis
Table 27. Amgen, Inc. Melanoma Therapeutics Product and Solutions
Table 28. Amgen, Inc. Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Daiichi Sankyo Company, Limited Corporate Information, Location and Competitors
Table 30. Daiichi Sankyo Company, Limited Melanoma Therapeutics Major Business
Table 31. Daiichi Sankyo Company, Limited Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 32. Daiichi Sankyo Company, Limited SWOT Analysis
Table 33. Daiichi Sankyo Company, Limited Melanoma Therapeutics Product and Solutions
Table 34. Daiichi Sankyo Company, Limited Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. F. Hoffmann-La Roche Ltd. Corporate Information, Location and Competitors
Table 36. F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Major Business
Table 37. F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 38. F. Hoffmann-La Roche Ltd. SWOT Analysis
Table 39. F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Product and Solutions
Table 40. F. Hoffmann-La Roche Ltd. Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Merck & Co., Inc. Corporate Information, Location and Competitors
Table 42. Merck & Co., Inc. Melanoma Therapeutics Major Business
Table 43. Merck & Co., Inc. Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 44. Merck & Co., Inc. SWOT Analysis
Table 45. Merck & Co., Inc. Melanoma Therapeutics Product and Solutions
Table 46. Merck & Co., Inc. Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Novartis AG Corporate Information, Location and Competitors
Table 48. Novartis AG Melanoma Therapeutics Major Business
Table 49. Novartis AG Melanoma Therapeutics Total Revenue (USD Million) (2017-2018)
Table 50. Novartis AG SWOT Analysis
Table 51. Novartis AG Melanoma Therapeutics Product and Solutions
Table 52. Novartis AG Melanoma Therapeutics Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Global Melanoma Therapeutics Revenue (Million USD) by Players (2015-2020)
Table 54. Global Melanoma Therapeutics Revenue Share by Players (2015-2020)
Table 55. Global Melanoma Therapeutics Revenue (Million USD) by Regions (2015-2020)
Table 56. Global Melanoma Therapeutics Revenue Market Share by Regions (2015-2020)
Table 57. North America Melanoma Therapeutics Revenue by Countries (2015-2020)
Table 58. North America Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Table 59. Europe Melanoma Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 60. Asia-Pacific Melanoma Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 61. South America Melanoma Therapeutics Revenue by Countries (2015-2020)
Table 62. South America Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Table 63. Middle East and Africa Melanoma Therapeutics Revenue (Million USD) by Countries (2015-2020)
Table 64. Middle East and Africa Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Table 65. Global Melanoma Therapeutics Revenue (Million USD) by Type (2015-2020)
Table 66. Global Melanoma Therapeutics Revenue Share by Type (2015-2020)
Table 67. Global Melanoma Therapeutics Revenue Forecast by Type (2021-2025)
Table 68. Global Melanoma Therapeutics Revenue by Application (2015-2020)
Table 69. Global Melanoma Therapeutics Revenue Share by Application (2015-2020)
Table 70. Global Melanoma Therapeutics Revenue Forecast by Application (2021-2025)
Table 71. Global Melanoma Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Melanoma Therapeutics Picture
Figure 2. Global Melanoma Therapeutics Revenue Market Share by Type in 2019
Figure 3. Chemotherapy Picture
Figure 4. Immunotherapy Picture
Figure 5. Targeted Therapy Picture
Figure 6. Radiation Therapy Picture
Figure 7. Melanoma Therapeutics Revenue Market Share by Application in 2019
Figure 8. Opdivo Picture
Figure 9. Yervoy Picture
Figure 10. Mekinist+Tafinlar Picture
Figure 11. Keytruda Picture
Figure 12. Cotellic Picture
Figure 13. Zelboraf Picture
Figure 14. Imlygic Picture
Figure 15. Generics Picture
Figure 16. Global Melanoma Therapeutics Revenue (USD Million) and Growth Rate (2015-2025)
Figure 17. North America Melanoma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Europe Melanoma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Asia-Pacific Melanoma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. South America Melanoma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Middle East and Africa Melanoma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 22. Global Melanoma Therapeutics Revenue (Million USD) and Growth Rate (2015-2025)
Figure 23. Global Melanoma Therapeutics Revenue Share by Players in 2019
Figure 24. Global Top 5 Players Melanoma Therapeutics Revenue Market Share in 2019
Figure 25. Global Top 10 Players Melanoma Therapeutics Revenue Market Share in 2019
Figure 26. Key Players Market Share Trend
Figure 27. Global Melanoma Therapeutics Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 28. Global Melanoma Therapeutics Revenue Market Share by Regions (2015-2020)
Figure 29. Global Melanoma Therapeutics Revenue Market Share by Regions in 2018
Figure 30. North America Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 31. Europe Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 32. Asia-Pacific Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 33. South America Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 34. Middle East and Africa Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 35. North America Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 36. North America Melanoma Therapeutics Revenue Market Share by Countries in 2019
Figure 37. USA Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 38. Canada Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 39. Mexico Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 40. Europe Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 41. Europe Melanoma Therapeutics Revenue Market Share by Countries in 2019
Figure 42. Germany Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 43. UK Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 44. France Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 45. Russia Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 46. Italy Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 47. Asia-Pacific Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 48. Asia-Pacific Melanoma Therapeutics Revenue Market Share by Countries in 2019
Figure 49. China Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 50. Japan Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 51. Korea Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 52. India Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 53. Southeast Asia Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 54. South America Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 55. South America Melanoma Therapeutics Revenue Market Share by Countries in 2019
Figure 56. Brazil Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 57. Argentina Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 58. Middle East and Africa Melanoma Therapeutics Revenue Market Share by Countries (2015-2020)
Figure 59. Middle East and Africa Melanoma Therapeutics Revenue Market Share by Countries in 2019
Figure 60. Saudi Arabia Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 61. UAE Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 62. Egypt Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 63. South Africa Melanoma Therapeutics Revenue and Growth Rate (2015-2020)
Figure 64. Global Melanoma Therapeutics Revenue Share by Type (2015-2020)
Figure 65. Global Melanoma Therapeutics Revenue Share by Type in 2019
Figure 66. Global Melanoma Therapeutics Market Share Forecast by Type (2021-2025)
Figure 67. Global Chemotherapy Revenue Growth Rate (2015-2020)
Figure 68. Global Immunotherapy Revenue Growth Rate (2015-2020)
Figure 69. Global Targeted Therapy Revenue Growth Rate (2015-2020)
Figure 70. Global Radiation Therapy Revenue Growth Rate (2015-2020)
Figure 71. Global Melanoma Therapeutics Revenue Share by Application (2015-2020)
Figure 72. Global Melanoma Therapeutics Revenue Share by Application in 2019
Figure 73. Global Melanoma Therapeutics Market Share Forecast by Application (2021-2025)
Figure 74. Global Opdivo Revenue Growth Rate (2015-2020)
Figure 75. Global Yervoy Revenue Growth Rate (2015-2020)
Figure 76. Global Mekinist+Tafinlar Revenue Growth Rate (2015-2020)
Figure 77. Global Keytruda Revenue Growth Rate (2015-2020)
Figure 78. Global Cotellic Revenue Growth Rate (2015-2020)
Figure 79. Global Zelboraf Revenue Growth Rate (2015-2020)
Figure 80. Global Imlygic Revenue Growth Rate (2015-2020)
Figure 81. Global Generics Revenue Growth Rate (2015-2020)
Figure 82. Global Melanoma Therapeutics Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 83. Global Melanoma Therapeutics Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 84. Global Melanoma Therapeutics Revenue Market Share Forecast by Regions (2021-2025)
Figure 85. North America Melanoma Therapeutics Revenue Market Forecast (2021-2025)
Figure 86. Europe Melanoma Therapeutics Revenue Market Forecast (2021-2025)
Figure 87. Asia-Pacific Melanoma Therapeutics Revenue Market Forecast (2021-2025)
Figure 88. South America Melanoma Therapeutics Revenue Market Forecast (2021-2025)
Figure 89. Middle East and Africa Melanoma Therapeutics Revenue Market Forecast (2021-2025)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
黒色腫がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Melanoma Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Melanoma Cancer market report…- ペット用がん治療の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Pet Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.9% in the forecast period of 2020 to 2025 and will expected to reach USD 206.2 million by 2025, from USD 164.2 million in 2019. The Pet Cancer The…
- 脳腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Brain Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 10.0% in the forecast period of 2020 to 2025 and will expected to reach USD 1552.3 million by 2025, from USD 1060.2 million in 2019. The Brain Tumo…
- 皮膚がん診断・治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin C…
- 固形腫瘍治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Solid Tumor Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.1% in the forecast period of 2020 to 2025 and will expected to reach USD 156810 million by 2025, from USD 114670 million in 2019. The Solid Tumor…